OBJECTIVE: To investigate the effects of the Intensive Cognitive and Communication Rehabilitation (ICCR) program for young adults with acquired brain injury (ABI) using a quasi-experimental pilot intervention study design while transitioning to remote implementation. METHOD: Twelve young adults with chronic ABI (treatment n = 7; control n = 5) participated in ICCR (i.e., lectures, seminars, individual cognitive rehabilitation (CR), technology training) for six hours/day, four days/week, for one or two 12-week semesters. Outcomes included classroom metrics, individual therapy performance, including Goal Attainment Scaling (GAS), standardized cognitive-linguistic assessments, and participation and health-related quality of life (QOL) measures. RESULTS: In the first semester (in-person and remote), treatment participants significantly improved in classroom exams; individual therapy (i.e., memory, writing, GAS); executive function and participation measures, but not QOL. In the second semester (remote), treatment participants significantly improved in classroom exams; essay writing; individual therapy (i.e., writing and GAS); and memory assessment, but not in participation or QOL. Treatment participants enrolled in consecutive semesters significantly improved in classroom exams, individual therapy (i.e., memory), participation and QOL, but not on standardized cognitive assessments. Controls demonstrated no significant group-level gains. CONCLUSION: These preliminary results highlight the benefit of intensive, integrated, and contextualized CR for this population and show promise for its remote delivery.
OBJECTIVE: To investigate the effects of the Intensive Cognitive and Communication Rehabilitation (ICCR) program for young adults with acquired brain injury (ABI) using a quasi-experimental pilot intervention study design while transitioning to remote implementation. METHOD: Twelve young adults with chronic ABI (treatment n = 7; control n = 5) participated in ICCR (i.e., lectures, seminars, individual cognitive rehabilitation (CR), technology training) for six hours/day, four days/week, for one or two 12-week semesters. Outcomes included classroom metrics, individual therapy performance, including Goal Attainment Scaling (GAS), standardized cognitive-linguistic assessments, and participation and health-related quality of life (QOL) measures. RESULTS: In the first semester (in-person and remote), treatment participants significantly improved in classroom exams; individual therapy (i.e., memory, writing, GAS); executive function and participation measures, but not QOL. In the second semester (remote), treatment participants significantly improved in classroom exams; essay writing; individual therapy (i.e., writing and GAS); and memory assessment, but not in participation or QOL. Treatment participants enrolled in consecutive semesters significantly improved in classroom exams, individual therapy (i.e., memory), participation and QOL, but not on standardized cognitive assessments. Controls demonstrated no significant group-level gains. CONCLUSION: These preliminary results highlight the benefit of intensive, integrated, and contextualized CR for this population and show promise for its remote delivery.
Authors: Keith D Cicerone; Yelena Goldin; Keith Ganci; Amy Rosenbaum; Jennifer V Wethe; Donna M Langenbahn; James F Malec; Thomas F Bergquist; Kristine Kingsley; Drew Nagele; Lance Trexler; Michael Fraas; Yelena Bogdanova; J Preston Harley Journal: Arch Phys Med Rehabil Date: 2019-03-26 Impact factor: 3.966
Authors: Ronda L Winans-Mitrik; William D Hula; Michael W Dickey; James G Schumacher; Brooke Swoyer; Patrick J Doyle Journal: Am J Speech Lang Pathol Date: 2014-05 Impact factor: 2.408
Authors: Brett M Kissela; Jane C Khoury; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Opeolu Adeoye; Matthew L Flaherty; Pooja Khatri; Simona Ferioli; Felipe De Los Rios La Rosa; Joseph P Broderick; Dawn O Kleindorfer Journal: Neurology Date: 2012-10-10 Impact factor: 9.910
Authors: Matthew W McDonald; Sandra E Black; David A Copland; Dale Corbett; Rick M Dijkhuizen; Tracy D Farr; Matthew S Jeffers; Rajesh N Kalaria; Frini Karayanidis; Alexander P Leff; Jess Nithianantharajah; Sarah Pendlebury; Terence J Quinn; Andrew N Clarkson; Michael J O'Sullivan Journal: Int J Stroke Date: 2019-09-12 Impact factor: 5.266
Authors: Richard C Gershon; Jin Shei Lai; Rita Bode; Seung Choi; Claudia Moy; Tom Bleck; Deborah Miller; Amy Peterman; David Cella Journal: Qual Life Res Date: 2011-08-27 Impact factor: 4.147
Authors: D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy Journal: Neurology Date: 2012-05-09 Impact factor: 9.910